Masa-aki Teranishi1, Tsutomu Nakashima. 1. Department of Otorhinolaryngology, Graduate School of Medicine, Nagoya University, 65, Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. masaaki@med.nagoya-u.ac.jp
Abstract
OBJECTIVE: Cisplatin (CDDP), an antitumor agent widely used in the treatment of pediatric solid tumors, has dose-limiting side effects such as ototoxicity and nephrotoxicity. Recently, evidence has been accumulated to demonstrate that these side effects are closely related to oxidative stress. In the present study, we attempted to suppress CDDP-induced ototoxicity in guinea pigs by administering trolox, a water-soluble analogue of alpha-tocopherol which is a natural lipid-soluble antioxidant, locally on round windows. METHODS: Hartley albino guinea pigs (250-300 g) were treated with CDDP (0.3 mg/ml) in the presence or absence of a combined treatment of trolox (5 mM). Both drugs were administered locally on round windows. RESULTS: The combined treatment of trolox distinctly improved the ototoxic side effects induced by CDDP. These were: elevation of auditory brain stem response threshold at 4, 8 and 16 kHz and substantial losses of outer hair cells with the base-to-apex gradient. CONCLUSION: Trolox, locally applied on round windows, showed a suppression on CDDP-ototoxicity. The results obtained in the present study suggest that a local application of trolox in the tympanic cavity can be a promising candidate to prevent the CDDP-ototoxicity in the future.
OBJECTIVE:Cisplatin (CDDP), an antitumor agent widely used in the treatment of pediatric solid tumors, has dose-limiting side effects such as ototoxicity and nephrotoxicity. Recently, evidence has been accumulated to demonstrate that these side effects are closely related to oxidative stress. In the present study, we attempted to suppress CDDP-induced ototoxicity in guinea pigs by administering trolox, a water-soluble analogue of alpha-tocopherol which is a natural lipid-soluble antioxidant, locally on round windows. METHODS: Hartley albino guinea pigs (250-300 g) were treated with CDDP (0.3 mg/ml) in the presence or absence of a combined treatment of trolox (5 mM). Both drugs were administered locally on round windows. RESULTS: The combined treatment of trolox distinctly improved the ototoxic side effects induced by CDDP. These were: elevation of auditory brain stem response threshold at 4, 8 and 16 kHz and substantial losses of outer hair cells with the base-to-apex gradient. CONCLUSION:Trolox, locally applied on round windows, showed a suppression on CDDP-ototoxicity. The results obtained in the present study suggest that a local application of trolox in the tympanic cavity can be a promising candidate to prevent the CDDP-ototoxicity in the future.
Authors: Numan Kökten; Oğuz Kadir Eğilmez; Murat Erinç; A Işın Doğan Ekici; Serkan Şerifler; Erdem Yeşilada; Mahmut Tayyar Kalcıoğlu Journal: J Int Adv Otol Date: 2020-12 Impact factor: 1.017
Authors: Mustafa Paksoy; Emin Ayduran; Arif Sanlı; Mehmet Eken; Sedat Aydın; Zeynep Alev Oktay Journal: Med Oncol Date: 2010-03-19 Impact factor: 3.064
Authors: Samson Jamesdaniel; Donald Coling; Sneha Hinduja; Dalian Ding; Jun Li; Linda Cassidy; Gail M Seigel; Jun Qu; Richard Salvi Journal: J Biol Chem Date: 2012-04-09 Impact factor: 5.157
Authors: Laura Astolfi; Edi Simoni; Filippo Valente; Sara Ghiselli; Stavros Hatzopoulos; Milvia Chicca; Alessandro Martini Journal: PLoS One Date: 2016-09-15 Impact factor: 3.240